IBIO, INC. Operating Cash Flow
IBIO, INC. (IBIO) reported Operating Cash Flow of -$23.22 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-28
- IBIO, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$6.23M.
- IBIO, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$6.08M.
- IBIO, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.24M.
- IBIO, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$5.67M.
- IBIO, INC. net cash provided by (used in) operating activities for fiscal 2026 was -$23.22M.
- IBIO, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$15.30M.
- IBIO, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$18.55M.
- IBIO, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$30.44M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | -$12.31M derived: sum of 2 quarters · filed 2026-08-28 | -$17.55M derived: sum of 3 quarters · filed 2026-08-28 | -$23.22M 10-K · filed 2026-08-28 | ||||
| 2026-03-31 | -$6.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | -$11.32M derived: sum of 2 quarters · filed 2026-05-12 | -$16.99M 10-Q · filed 2026-05-12 | -$21.61M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | -$5.24M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-10 | -$10.91M 10-Q · filed 2026-02-10 | -$15.52M derived: sum of 3 quarters · filed 2026-08-28 | -$18.63M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-09-30 | -$5.67M 10-Q/A · filed 2025-11-17 | -$10.28M derived: sum of 2 quarters · filed 2026-08-28 | -$13.38M derived: sum of 3 quarters · filed 2026-08-28 | -$17.25M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-06-30 | -$4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | -$7.72M derived: sum of 2 quarters · filed 2026-08-28 | -$11.59M derived: sum of 3 quarters · filed 2026-08-28 | -$15.30M 10-K · filed 2026-08-28 | ||||
| 2025-03-31 | -$3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | -$6.97M derived: sum of 2 quarters · filed 2026-05-12 | -$10.69M 10-Q · filed 2026-05-12 | -$15.54M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$3.87M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2026-02-10 | -$7.58M 10-Q · filed 2026-02-10 | -$12.44M derived: sum of 3 quarters · filed 2026-02-10 | -$16.09M derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-09-30 | -$3.71M 10-Q/A · filed 2025-11-17 | -$8.57M derived: sum of 2 quarters · filed 2025-11-17 | -$12.22M derived: sum of 3 quarters · filed 2025-11-17 | -$16.93M derived: sum of 4 quarters · filed 2025-11-17 | ||||
| 2024-06-30 | -$4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-05 | -$8.51M derived: sum of 2 quarters · filed 2025-09-05 | -$13.21M derived: sum of 3 quarters · filed 2025-09-05 | -$18.55M 10-K · filed 2025-09-05 | ||||
| 2024-03-31 | -$3.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-02 | -$8.36M derived: sum of 2 quarters · filed 2025-05-02 | -$13.70M 10-Q · filed 2025-05-02 | -$18.67M derived: sum of 4 quarters · filed 2025-05-02 | ||||
| 2023-12-31 | -$4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-10 | -$10.05M 10-Q · filed 2025-02-10 | -$15.02M derived: sum of 3 quarters · filed 2025-02-10 | -$18.89M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-09-30 | -$5.34M 10-Q · filed 2024-11-12 | -$10.31M derived: sum of 2 quarters · filed 2024-11-12 | -$14.18M derived: sum of 3 quarters · filed 2024-11-12 | -$21.82M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$4.97M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-24 | -$8.84M derived: sum of 2 quarters · filed 2024-09-24 | -$16.48M derived: sum of 3 quarters · filed 2024-09-24 | -$30.44M 10-K/A · filed 2024-09-24 | ||||
| 2023-03-31 | -$3.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-13 | -$11.51M derived: sum of 2 quarters · filed 2024-05-13 | -$25.47M 10-Q · filed 2024-05-13 | -$36.97M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | -$7.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-09 | -$21.59M 10-Q · filed 2024-02-09 | -$33.10M derived: sum of 3 quarters · filed 2024-02-09 | -$39.04M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-09-30 | -$13.96M 10-Q · filed 2023-11-14 | -$25.46M derived: sum of 2 quarters · filed 2023-11-14 | -$31.41M derived: sum of 3 quarters · filed 2023-11-14 | -$42.09M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-27 | -$17.45M derived: sum of 2 quarters · filed 2023-09-27 | -$28.13M derived: sum of 3 quarters · filed 2023-09-27 | -$37.48M 10-K · filed 2023-09-27 | ||||
| 2022-03-31 | -$5.94M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-05-15 | -$16.63M derived: sum of 2 quarters · filed 2023-05-19 | -$25.98M 10-Q · filed 2023-05-15 | -$33.20M derived: sum of 4 quarters · filed 2023-05-19 | ||||
| 2021-12-31 | -$10.69M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-05-19 | -$20.03M 10-Q/A · filed 2023-05-19 | -$27.26M derived: sum of 3 quarters · filed 2023-05-19 | -$34.61M derived: sum of 4 quarters · filed 2023-05-19 | ||||
| 2021-09-30 | -$9.35M 10-Q · filed 2022-11-14 | -$16.57M derived: sum of 2 quarters · filed 2022-11-14 | -$23.92M derived: sum of 3 quarters · filed 2022-11-14 | -$32.34M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$7.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-11 | -$14.57M derived: sum of 2 quarters · filed 2022-10-11 | -$22.99M derived: sum of 3 quarters · filed 2022-10-11 | -$30.06M 10-K · filed 2022-10-11 | ||||
| 2021-03-31 | -$7.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-12 | -$15.77M derived: sum of 2 quarters · filed 2022-05-12 | -$22.84M 10-Q · filed 2022-05-12 | -$26.70M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$8.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | -$15.49M 10-Q · filed 2022-02-14 | -$19.36M derived: sum of 3 quarters · filed 2022-02-14 | -$23.14M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-09-30 | -$7.07M 10-Q · filed 2021-11-15 | -$10.94M derived: sum of 2 quarters · filed 2021-11-15 | -$14.72M derived: sum of 3 quarters · filed 2021-11-15 | -$18.13M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | -$7.65M derived: sum of 2 quarters · filed 2021-09-28 | -$11.06M derived: sum of 3 quarters · filed 2021-09-28 | -$13.35M 10-K · filed 2021-09-28 | ||||
| 2020-03-31 | -$3.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-17 | -$7.19M derived: sum of 2 quarters · filed 2021-05-17 | -$9.48M 10-Q · filed 2021-05-17 | -$13.87M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | -$3.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | -$5.69M 10-Q · filed 2021-02-16 | -$10.08M derived: sum of 3 quarters · filed 2021-02-16 | -$14.22M derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | -$2.29M 10-Q · filed 2020-11-16 | -$6.68M derived: sum of 2 quarters · filed 2020-11-16 | -$10.81M derived: sum of 3 quarters · filed 2020-11-16 | -$15.48M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | -$4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | -$8.53M derived: sum of 2 quarters · filed 2020-10-13 | -$13.20M derived: sum of 3 quarters · filed 2020-10-13 | -$13.97M 10-K · filed 2020-10-13 | ||||
| 2019-03-31 | -$4.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-15 | -$8.80M derived: sum of 2 quarters · filed 2020-05-15 | -$9.58M 10-Q · filed 2020-05-15 | -$12.96M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | -$4.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | -$5.45M 10-Q · filed 2020-02-14 | -$8.82M derived: sum of 3 quarters · filed 2020-02-14 | -$12.32M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-09-30 | -$778.00K 10-Q · filed 2019-11-14 | -$4.15M derived: sum of 2 quarters · filed 2019-11-14 | -$7.65M derived: sum of 3 quarters · filed 2019-11-14 | -$11.24M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | -$3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-26 | -$6.88M derived: sum of 2 quarters · filed 2019-08-26 | -$10.46M derived: sum of 3 quarters · filed 2019-08-26 | -$13.48M 10-K · filed 2019-08-26 | ||||
| 2018-03-31 | -$3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | -$7.09M derived: sum of 2 quarters · filed 2019-05-10 | -$10.11M 10-Q · filed 2019-05-10 | -$13.87M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | -$3.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | -$6.61M 10-Q · filed 2019-02-13 | -$10.37M derived: sum of 3 quarters · filed 2019-02-13 | -$13.93M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-09-30 | -$3.02M 10-Q · filed 2018-11-13 | -$6.78M derived: sum of 2 quarters · filed 2018-11-13 | -$10.34M derived: sum of 3 quarters · filed 2018-11-13 | -$13.91M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-18 | -$7.33M derived: sum of 2 quarters · filed 2018-09-18 | -$10.89M derived: sum of 3 quarters · filed 2018-09-18 | -$13.16M 10-K · filed 2018-09-18 | ||||
| 2017-03-31 | -$3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-11 | -$7.13M derived: sum of 2 quarters · filed 2018-05-11 | -$9.40M 10-Q · filed 2018-05-11 | |||||
| 2016-12-31 | -$3.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | -$5.84M 10-Q · filed 2018-02-14 | ||||||
| 2016-09-30 | -$2.27M 10-Q · filed 2017-11-09 | |||||||
| 2013-12-31 | $3.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-14 | $2.20M 10-Q · filed 2014-02-14 | -$6.55M derived: sum of 3 quarters · filed 2014-02-14 | $45.00K derived: sum of 4 quarters · filed 2014-02-14 | ||||
| 2013-09-30 | -$911.00K 10-Q · filed 2013-11-14 | -$9.66M derived: sum of 2 quarters · filed 2013-11-14 | -$3.07M derived: sum of 3 quarters · filed 2013-11-14 | -$4.47M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2013-06-30 | -$8.75M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-10-04 | -$2.15M derived: sum of 2 quarters · filed 2013-10-04 | -$3.56M derived: sum of 3 quarters · filed 2013-10-04 | -$4.85M 10-K/A · filed 2013-10-04 | ||||
| 2013-03-31 | $6.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-20 | $5.19M derived: sum of 2 quarters · filed 2013-05-20 | $3.90M 10-Q · filed 2013-05-20 | -$7.11M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-12-31 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-19 | -$2.69M 10-Q · filed 2013-02-19 | -$13.70M derived: sum of 3 quarters · filed 2013-11-14 | -$10.72M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-09-30 | -$1.29M 10-Q · filed 2013-11-14 | -$1.29M 10-Q · filed 2012-11-14 | -$12.30M derived: sum of 2 quarters · filed 2013-11-14 | -$9.31M derived: sum of 3 quarters · filed 2013-11-14 | -$6.07M derived: sum of 4 quarters · filed 2013-11-14 | |||
| 2012-06-30 | -$11.01M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-10-04 | -$8.02M derived: sum of 2 quarters · filed 2013-10-04 | -$4.78M derived: sum of 3 quarters · filed 2013-10-04 | -$6.01M 10-K/A · filed 2013-10-04 | -$6.01M 10-K/A · filed 2012-10-15 | |||
| 2012-03-31 | $2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-20 | $6.23M derived: sum of 2 quarters · filed 2013-05-20 | $5.00M 10-Q · filed 2013-05-20 | -$4.97M 10-Q · filed 2012-05-15 | $3.90M derived: sum of 4 quarters · filed 2013-05-20 | |||
| 2011-12-31 | $3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-19 | $2.01M 10-Q · filed 2013-02-19 | -$2.01M 10-Q · filed 2012-02-14 | $913.45K derived: sum of 3 quarters · filed 2013-02-19 | -$1.09M derived: sum of 4 quarters · filed 2013-02-19 | |||
| 2011-09-30 | -$1.23M 10-Q · filed 2012-11-14 | -$2.33M derived: sum of 2 quarters · filed 2012-11-14 | -$4.34M derived: sum of 3 quarters · filed 2012-11-14 | -$6.04M derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | -$1.10M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-15 | -$3.11M derived: sum of 2 quarters · filed 2012-10-15 | -$4.81M derived: sum of 3 quarters · filed 2012-10-15 | -$5.34M 10-K/A · filed 2012-10-15 | ||||
| 2011-03-31 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | -$3.71M derived: sum of 2 quarters · filed 2012-05-15 | -$4.24M 10-Q · filed 2012-05-15 | |||||
| 2010-12-31 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | -$2.23M 10-Q · filed 2012-02-14 | ||||||
| 2010-09-30 | -$526.23K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |